See more : Blonder Tongue Laboratories, Inc. (BDRL) Income Statement Analysis – Financial Results
Complete financial analysis of Aikchol Hospital Public Company Limited (AHC.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aikchol Hospital Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Unity Bancorp, Inc. (UNTY) Income Statement Analysis – Financial Results
- gremz,Inc. (GRMZF) Income Statement Analysis – Financial Results
- Investeringsforeningen Danske Invest – USA – Akkumulerende KL (DKIUSAIAKKDKKH.CO) Income Statement Analysis – Financial Results
- Oliveda International, Inc. (OLVI) Income Statement Analysis – Financial Results
- Numinus Wellness Inc. (NUMIF) Income Statement Analysis – Financial Results
Aikchol Hospital Public Company Limited (AHC.BK)
About Aikchol Hospital Public Company Limited
Aikchol Hospital Public Company Limited provides medical and nursing care services under the Aikchol Hospital trademark in Thailand. The company offers various hospital services comprising diseases protection, medical treatment, health strengthening, and health rehabilitation services with 310 beds in service. It serves primarily individuals, group of policyholders of the insurance company, group of contract parties' company, and group of insured on social security. Aikchol Hospital Public Company Limited was founded in 1978 is headquartered in Chonburi, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.83B | 1.96B | 1.83B | 1.42B | 1.67B | 1.65B | 1.56B | 1.60B | 1.51B | 1.49B | 1.40B | 1.26B | 1.07B | 983.65M | 853.81M | 897.92M | 785.13M | 750.87M |
| Cost of Revenue | 1.37B | 1.44B | 1.41B | 1.24B | 1.43B | 1.38B | 1.32B | 1.29B | 1.21B | 1.19B | 1.05B | 967.02M | 853.99M | 779.40M | 699.61M | 703.23M | 648.19M | 547.20M |
| Gross Profit | 456.25M | 519.24M | 417.68M | 174.37M | 234.06M | 266.07M | 243.52M | 311.59M | 298.51M | 301.55M | 343.10M | 296.99M | 217.23M | 204.26M | 154.20M | 194.69M | 136.94M | 203.67M |
| Gross Profit Ratio | 24.94% | 26.49% | 22.88% | 12.29% | 14.03% | 16.13% | 15.61% | 19.51% | 19.76% | 20.18% | 24.59% | 23.50% | 20.28% | 20.76% | 18.06% | 21.68% | 17.44% | 27.12% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 221.88M | 208.78M | 120.33M | 106.36M | 97.28M | 113.57M | 109.09M | 108.16M | 119.98M | 105.26M | 105.84M | 96.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -24.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 221.88M | 208.78M | 120.33M | 106.36M | 97.28M | 113.57M | 109.09M | 108.16M | 119.98M | 105.26M | 81.14M | 96.54M | 89.19M | 84.06M | 82.50M | 88.56M | 72.68M | 53.44M |
| Other Expenses | 0.00 | 24.29M | 22.41M | 18.38M | 21.04M | 16.44M | 7.63M | 17.44M | 11.64M | 9.78M | 8.11M | 9.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 221.88M | 208.78M | 120.33M | 106.36M | 97.28M | 113.57M | 98.23M | 108.16M | 117.73M | 90.66M | 105.84M | 85.16M | 89.19M | 84.06M | 82.50M | 88.56M | 72.68M | 53.44M |
| Cost & Expenses | 1.59B | 1.65B | 1.53B | 1.35B | 1.53B | 1.50B | 1.41B | 1.39B | 1.33B | 1.28B | 1.16B | 1.05B | 943.18M | 863.45M | 782.11M | 791.79M | 720.87M | 600.64M |
| Interest Income | 1.33M | 3.80M | 1.86M | 3.26M | 7.37M | 5.57M | 5.54M | 5.94M | 6.84M | 5.53M | 4.42M | 3.05M | 1.29M | 0.00 | 0.00 | 1.18M | 3.10M | 0.00 |
| Interest Expense | 185.12K | 200.08K | 124.47K | 195.28K | 0.00 | 5.57M | 5.54M | 5.94M | 0.00 | 0.00 | 0.00 | 0.00 | 3.25M | 7.93M | 11.70M | 16.26M | 17.95M | 19.10M |
| Depreciation & Amortization | 75.05M | 70.72M | 68.72M | 68.73M | 63.33M | 60.45M | 59.60M | 61.95M | 57.89M | 52.51M | 51.51M | 48.70M | 47.94M | 46.28M | 45.61M | 42.90M | 37.79M | 22.29M |
| EBITDA | 309.42M | 409.25M | 390.33M | 158.38M | 200.11M | 212.96M | 218.07M | 288.75M | 257.16M | 278.72M | 288.78M | 272.62M | 194.50M | 166.48M | 117.31M | 132.60M | 120.00M | 191.62M |
| EBITDA Ratio | 16.92% | 20.88% | 21.39% | 11.16% | 11.99% | 12.91% | 13.13% | 16.62% | 15.80% | 17.62% | 20.69% | 21.57% | 16.43% | 16.92% | 13.74% | 14.77% | 15.28% | 25.52% |
| Operating Income | 234.38M | 338.54M | 321.62M | 89.65M | 136.78M | 152.51M | 158.46M | 203.42M | 199.26M | 226.20M | 237.26M | 200.46M | 128.05M | 120.20M | 71.70M | 89.70M | 82.21M | 169.33M |
| Operating Income Ratio | 12.81% | 17.27% | 17.62% | 6.32% | 8.20% | 9.24% | 10.16% | 12.74% | 13.19% | 15.13% | 17.00% | 15.86% | 11.95% | 12.22% | 8.40% | 9.99% | 10.47% | 22.55% |
| Total Other Income/Expenses | -185.12K | -200.08K | -124.47K | -195.28K | 0.00 | 22.01M | 13.17M | 23.38M | 10.63M | 8.56M | 0.00 | 23.46M | 18.51M | -7.93M | -11.70M | -16.26M | -17.95M | -38.21M |
| Income Before Tax | 234.19M | 338.34M | 321.49M | 89.46M | 165.19M | 174.52M | 158.46M | 226.80M | 199.26M | 226.20M | 237.26M | 223.92M | 146.56M | 112.27M | 60.01M | 89.87M | 64.26M | 150.23M |
| Income Before Tax Ratio | 12.80% | 17.26% | 17.61% | 6.30% | 9.90% | 10.58% | 10.16% | 14.20% | 13.19% | 15.13% | 17.00% | 17.71% | 13.68% | 11.41% | 7.03% | 10.01% | 8.18% | 20.01% |
| Income Tax Expense | 45.43M | 67.28M | 63.05M | 17.26M | 32.04M | 33.80M | 30.60M | 44.26M | 39.05M | 44.51M | 46.77M | 51.56M | 44.81M | 27.56M | 14.91M | 24.20M | 11.13M | 34.63M |
| Net Income | 188.76M | 271.05M | 258.44M | 72.20M | 133.15M | 140.72M | 127.87M | 182.54M | 160.21M | 181.69M | 190.50M | 172.36M | 101.75M | 84.71M | 45.10M | 65.67M | 35.18M | 96.49M |
| Net Income Ratio | 10.32% | 13.83% | 14.16% | 5.09% | 7.98% | 8.53% | 8.20% | 11.43% | 10.61% | 12.16% | 13.65% | 13.64% | 9.50% | 8.61% | 5.28% | 7.31% | 4.48% | 12.85% |
| EPS | 1.26 | 1.81 | 1.72 | 0.48 | 0.89 | 0.94 | 0.85 | 1.22 | 1.07 | 1.21 | 1.27 | 1.15 | 0.68 | 0.56 | 0.30 | 0.44 | 0.23 | 0.64 |
| EPS Diluted | 1.26 | 1.81 | 1.72 | 0.48 | 0.89 | 0.94 | 0.85 | 1.22 | 1.07 | 1.21 | 1.27 | 1.15 | 0.68 | 0.56 | 0.30 | 0.44 | 0.23 | 0.64 |
| Weighted Avg Shares Out | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 150.00M | 150.00M | 150.00M | 150.00M | 150.00M | 150.00M |
| Weighted Avg Shares Out (Dil) | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 149.91M | 150.00M | 150.00M | 150.00M | 150.00M | 150.00M | 150.00M |
Source: https://incomestatements.info
Category: Stock Reports